HAART, side effects, and viral transmission
Laurence, J.
Aids Reader 14(5): 210-211
2004
ISSN/ISBN: 1053-0894 PMID: 15198078 Document Number: 567584
Document emailed within 1 workday
Related Documents
Chandrasekhar, A.; Gupta, A. 2011: Nutrition and disease progression pre-highly active antiretroviral therapy (HAART) and post-HAART: can good nutrition delay time to HAART and affect response to HAART? American Journal of Clinical Nutrition 94(6): 1703s-1715sPander Maat, H.; Klaassen, R. 1996: The effect of the wording of information about side effects on patients' interpretation of reported side effects Nederlands Tijdschrift Voor Geneeskunde 140(8): 424-427
Britton, S. 2013: Vaccines must have a minimal amount of side effects. Serious side effects threatens public trust Lakartidningen 110(16): 816
Peña, Aía.; Cerón, Iés.; Budnik, I.; Barttlet, D.; Cataldo, K.; Fernández, A.M.; Ramírez, Aía.; Lasso, Mín. 2013: Prevention of vertical transmission and side effects of antiretroviral therapy in children born to HIV-positive South Eastern area of Santiago, Chile: 15-years perspective Revista Chilena de Infectologia: Organo Oficial de la Sociedad Chilena de Infectologia 30(6): 644-652
Tornero, C.; Gimeno, Cón.; Igual, R.; Santamaría, A.; Gil, E.; Rull, S. 2003: Effect of HAART on HCV viral load in the first three years of follow-up Medicina clinica 121(11): 408-409
Liu, Y.; Dong, J.-P.; Zou, W.; Gao, G.-J.; Wang, J. 2013: Research progress of Chinese medicine treatment of HAART-related toxic and side effect Zhongguo Zhong Yao Za Zhi 38(15): 2527-2529
Pillonel, J.; Saura, C.; Courouce, A.M. 1998: Dépistage des marqueurs d'une infection par le VIH et les virus des hépatites B et C chez les donneurs de sang en France et risque résiduel de transmission de ces virus par transfusion sanguine - Screening of viral markers for HIV, HBV and HCV infections in blood donors in france and residual risk of viral transmission by blood transfusion Euro Surveillance 3(7): 76-79
Chibwesha, C.J.; Giganti, M.J.; Putta, N.; Chintu, N.; Mulindwa, J.; Dorton, B.J.; Chi, B.H.; Stringer, J.S.A.; Stringer, E.M. 2011: Optimal time on HAART for prevention of mother-to-child transmission of HIV Journal of Acquired Immune Deficiency Syndromes 58(2): 224-228
Shapiro, R.L.; Kitch, D.; Ogwu, A.; Hughes, M.D.; Lockman, S.; Powis, K.; Souda, S.; Moffat, C.; Moyo, S.; McIntosh, K.; van Widenfelt, E.; Zwerski, S.; Mazhani, L.; Makhema, J.; Essex, M. 2013: HIV transmission and 24-month survival in a randomized trial of HAART to prevent MTCT during pregnancy and breastfeeding in Botswana Aids 27(12): 1911-1920
Shapiro, R.L.; Kitch, D.; Ogwu, A.; Hughes, M.D.; Lockman, S.; Powis, K.; Souda, S.; Moffat, C.; Moyo, S.; McIntosh, K.; van Widenfelt, E.; Zwerski, S.; Mazhani, L.; Makhema, J.; Essex, M. 2013: HIV transmission and 24-month survival in a randomized trial of HAART to prevent MTCT during pregnancy and breastfeeding in Botswana Aids 27(12): 1911-1920
Dinbar, A.; Fonkalsrud, E.W. 1971: Enzmatic and histologic effects of side-to-side portacaval anastomosis on the primate liver Surgery Gynecology and Obstetrics 133(1): 35-38
Estill, J.; Aubrière, C.; Egger, M.; Johnson, L.; Wood, R.; Garone, D.; Gsponer, T.; Wandeler, G.; Boulle, A.; Davies, M.-A.; Hallett, T.B.; Keiser, O. 2012: Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: a mathematical modelling analysis Aids 26(11): 1403-1413
Gromashevskiĭ, L.V.; Vasil'eva, V.L. 1972: Evolution of viruses and viral diseases. I. Evolution of viral parasitism in relation to the mechanism of transmission of the causative agents Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 49(12): 44-48
Menezes, A.éi.M.; Torelly, J.; Real, L.úc.; Bay, M.ôn.; Poeta, J.; Sprinz, E. 2011: Prevalence and risk factors associated to chronic kidney disease in HIV-infected patients on HAART and undetectable viral load in Brazil Plos one 6(10): E26042
Kouanda, S.; Tougri, H.; Cisse, M.; Simpore, J.; Pietra, V.; Doulougou, B.; Ouedraogo, G.; Ouedraogo, C.Marie.; Soudre, R.; Sondo, B. 2010: Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso Aids Care 22(7): 843-850
Linguissi, L.Stella.Ghoma.; Bisseye, C.; Sagna, T.; Nagalo, B.Marius.; Ouermi, D.; Djigma, F.W.; Pignatelli, S.; Sia, J.D.; Pietra, V.; Moret, R.; Nikiema, J.Baptiste.; Simpore, J. 2012: Efficiency of HAART in the prevention of mother to children HIV-1 transmission at Saint Camille medical centre in Burkina Faso, West Africa Asian Pacific Journal of Tropical Medicine 5(12): 991-994
Hasson, H.; Saniabadi, A.; Alfano, M.; Trabattoni, D.; Ferrante, P.; Lillo, F.; Clerici, M.; Lazzarin, A.; Beretta, A. 2002: Granulocyte/monocyte apheresis induces sustained increases in CD4 T cells in HIV-1 infected patients with poor CD4 T cell restoration after suppression of viral replication by HAART Journal of Biological Regulators and Homeostatic Agents 16(1): 58-63
Gautam, H.; Bhalla, P.; Saini, S.; Dewan, R. 2008: Correlation between baseline CD4 + T-Lymphocyte count and plasma viral load in AIDS patients and their early clinical and immunological response to HAART: a preliminary study Indian Journal of Medical Microbiology 26(3): 256-258
Van Vaerenbergh, K.; Harrer, T.; Schmit, J-C.; Carbonez, A.; Fontaine, E.; Kurowski, M.; Grünke, M.; Löw, P.; Rascu, A.; Schmidt, B.; Schmitt, M.; Thoelen, I.; Walter, H.; Van Laethem, K.; Van Ranst, M.; Desmyter, J.; De Clercq, E.; Vandamme, A-M. 2002: Initiation of HAART in drug-naive HIV type 1 patients prevents viral breakthrough for a median period of 35.5 months in 60% of the patients Aids Research and Human Retroviruses 18(6): 419-426
Greene, J. 2002: Side by side. Communication is key to a successful side by side CEO-board chair partnership Trustee: the Journal for Hospital Governing Boards 55(5): 6